Precitype HCC

This is a 68-gene panel test that measures mRNA expression of genes related to proliferation, cancer immunity, extracellular matrix，extracellular exosome，FTH and house-keeping. Intrinsic subtype, proliferation score and immunity score are combined to calculate Risk of recurrence score for evaluation of the prognosis of primary hepatocellular cancer patients.

Applications:
1. Evaluation of risk of distant metastasis 
2. Prediction of benefit from sorafenib treatment.
3. Intrinsic subtype-based treatment strategy

Patients:
Hepatocellular cancer patients

Platform:
Illumina NGS RNA-seq